Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US. Read More
Three Indian pharmaceutical companies have started supplying Nepal with life-saving anti-viral Remdesivir to be used for the treatment of COVID-19 patients. ...
Pharmaceutical company Mylan on Monday announced the commercial launch of its Remdesivir under the brand name DESREMTM in India to address urgent, unmet needs amid COVID-19 pandemic. ...
Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial. ...
The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for 'restricted emergency use' on hospitalised COVID-19 patients, a senior government official said on T ...
Biotech major Biocon said here on Thursday its insulin Glargine Semglee, co-developed with Mylan to treat diabetes, was available in Australia under the pharmaceutical benefits scheme (PBS). ...